Background <p>Allergic rhinitis (AR) can substantially impair quality of life (QOL), particularly in patients refractory to maximal medical therapy. Endoscopic posterior nasal nerve neurectomy (PNN) is a surgical option that preserves mucosa and aims to reduce nasal rhinorrhea, congestion, and sneezing.</p> Methods <p>This prospective single arm interventional study was conducted on 40 patients with AR symptoms refractory to maximum medical therapy. Patients underwent endoscopic PNN and were evaluated preoperatively and postoperatively using validated scores and endoscopic nasal examination. This work aimed to assess the efficacy and outcome of endoscopic PNN in patients with AR.</p> Results <p>Visual Analogue Scale (VAS) scores for sneezing, rhinorrhea, nasal congestion, itching, and postnasal drip showed marked reduction, with approximately 90% of patients reporting none-to-occasional symptoms by 6 months. Endoscopic grading demonstrated substantial improvement in nasal airway patency, with a decrease in higher obstruction grades over time (<i>P</i> &lt; 0.001). QOL improved substantially, with median QOL scores increasing from 2 preoperatively to 7 at 6 months. Post-operative complications were mild and transient, with no major adverse events reported.</p> Conclusion <p>Endoscopic PNN neurectomy was a safe and effective treatment for AR, providing substantial symptom relief, improved nasal airway patency, and marked enhancement in QOL.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Endoscopic posterior nasal nerve neurectomy efficacy and outcome in cases of allergic rhinitis

  • Essam Abd El-Wanees Behary,
  • Mohammed El-Sharnoby,
  • Alshaymaa Abdelmoaty Mohamed Elmaghrby,
  • Sohair Reda Aboshady

摘要

Background

Allergic rhinitis (AR) can substantially impair quality of life (QOL), particularly in patients refractory to maximal medical therapy. Endoscopic posterior nasal nerve neurectomy (PNN) is a surgical option that preserves mucosa and aims to reduce nasal rhinorrhea, congestion, and sneezing.

Methods

This prospective single arm interventional study was conducted on 40 patients with AR symptoms refractory to maximum medical therapy. Patients underwent endoscopic PNN and were evaluated preoperatively and postoperatively using validated scores and endoscopic nasal examination. This work aimed to assess the efficacy and outcome of endoscopic PNN in patients with AR.

Results

Visual Analogue Scale (VAS) scores for sneezing, rhinorrhea, nasal congestion, itching, and postnasal drip showed marked reduction, with approximately 90% of patients reporting none-to-occasional symptoms by 6 months. Endoscopic grading demonstrated substantial improvement in nasal airway patency, with a decrease in higher obstruction grades over time (P < 0.001). QOL improved substantially, with median QOL scores increasing from 2 preoperatively to 7 at 6 months. Post-operative complications were mild and transient, with no major adverse events reported.

Conclusion

Endoscopic PNN neurectomy was a safe and effective treatment for AR, providing substantial symptom relief, improved nasal airway patency, and marked enhancement in QOL.